| Exocrine Pancreatic Insufficiency After Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy (NCT05480241) | Unidade Local de Saúde de Coimbra, EPE | 2022-05-01 |
| Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes (NCT05385211) | Ciusss de L'Est de l'Île de Montréal | 2022-04-30 |
| Endotherapy for Painless Chronic Pancreatitis (NCT05261997) | Changhai Hospital | 2022-03-01 |
| Oral CDX-7108 in Healthy Adults and EPI Subjects (NCT05082051) | Société des Produits Nestlé (SPN) | 2021-10-11 |
| The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding (NCT05112328) | Seoul National University Hospital | 2021-07-07 |
| BÜHLMANN FPELA in the Diagnosis of Exocrine Pancreatic Insufficiency (NCT04548778) | Bühlmann Laboratories AG | 2020-11-01 |
| Role of Pancreatic Exocrine Secretion in Weight Gain After Pancreas Transplantation (NCT04690738) | Rush University Medical Center | 2020-08-17 |
| Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer (NCT04112836) | Moscow Clinical Scientific Center | 2019-03-15 |
| Assessment of a PERT-free Nutritional Therapeutic Delivery System for Cystic Fibrosis (NCT04966897) | GlycosBio, Inc. | 2018-08-31 |
| Prevalence of Exocrine Pancreatic Insufficiency in Patients With Decompensated Cirrhosis (NCT03236038) | Corporacion Parc Tauli | 2017-10-01 |
| EASY: Extended Access to Sollpura Over Years (NCT02823964) | Anthera Pharmaceuticals | 2016-09-01 |
| SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis (NCT02734810) | Anthera Pharmaceuticals | 2016-06-01 |
| Detection of Exocrine Pancreatic Insufficiency in Patients With Diarrhea and Bloating (NCT03407534) | Baylor College of Medicine | 2015-11-01 |
| Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb) (NCT02598128) | Alcresta Therapeutics, Inc. | 2015-11-01 |
| Pancreatic Exocrine Insufficiency in Acute Pancreatitis (NCT02563080) | Helsinki University Central Hospital | 2015-09-01 |
| SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis (NCT02279498) | Anthera Pharmaceuticals | 2015-06-01 |
| A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI (NCT02370537) | AstraZeneca | 2015-03-01 |
| Baby Observational and Nutritional Study (NCT01424696) | Seattle Children's Hospital | 2011-12-01 |
| Enzyme Suppletion in Exocrine Pancreatic Dysfunction (NCT01430234) | Foundation for Liver Research | 2011-10-01 |
| Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency (NCT01427725) | Mylan Inc. | 2011-09-01 |
| Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis (NCT01427712) | Mylan Inc. | 2011-08-01 |
| Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency (NCT01327703) | Forest Laboratories | 2011-04-01 |
| Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy (NCT02175459) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2010-08-01 |
| PR-018: An Open-Label, Safety Extension of Study PR-011 (NCT01131507) | Forest Laboratories | 2010-07-01 |
| A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age (NCT01100606) | Forest Laboratories | 2010-06-01 |
| Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients (NCT00663975) | Digestive Care, Inc. | 2009-02-01 |
| A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency (NCT00662675) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-08-01 |
| Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency (NCT00743483) | Swedish Orphan Biovitrum | 2008-08-01 |
| Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control (NCT00744250) | Digestive Care, Inc. | 2008-08-01 |
| A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI) (NCT00676702) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-07-01 |
| An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI) (NCT00559052) | Axcan Pharma | 2008-03-01 |
| A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI) (NCT00788593) | Forest Laboratories | 2008-01-01 |
| Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea (NCT00559364) | Forest Laboratories | 2007-11-01 |
| Open-Label Phase III Long-Term Safety Trial of Liprotamase (NCT00449904) | Anthera Pharmaceuticals | 2007-06-01 |
| Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency (NCT00449878) | Anthera Pharmaceuticals | 2007-05-01 |
| Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum) (NCT00749099) | Digestive Care, Inc. | 2007-04-01 |
| Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI) (NCT00408317) | Forest Laboratories | 2006-11-01 |
| Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency (NCT00297167) | Forest Laboratories | 2006-05-01 |
| Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency (NCT00981214) | Forest Laboratories | 2006-05-01 |